Pharmafile Logo

NEW WEBINAR: Maximizing Speed-to-Outcome for Life Science Companies

Stop losing momentum to the “logistics lag.” The most successful life science teams have moved beyond fragmented spreadsheets and isolated meetings into a unified orchestration engine. Learn the strategies that will cut your project timelines by 50%!

- PMLiVE

About the webinar

The most successful life science teams have stopped treating stakeholder engagement as a series of isolated events and started treating it as a continuous production line. By moving beyond the “meeting” and into a unified, automated matrix, you can cut project timelines by 50% while producing higher-quality, peer-vetted outputs.

Join us on May 12-13 to discover how a centralized orchestration engine can streamline your most complex global projects and maximize your speed-to-outcome. We’ll cover how to:

  • Bridge the Insight-to-Action Gap: Transform expert dialogue directly into drafted manuscripts and clinical assets, cutting months off the transition from “meeting” to “submission.”

  • Orchestrate a Unified Matrix: Move away from manual notifications and multiple spreadsheets. See how one platform centralizes simultaneous workstreams, automated reminders, and real-time analytics.

  • Build a Consensus-Building Engine: Streamline the development of practical guidelines and medical messaging through asynchronous alignment that ensures accuracy without the administrative overhead.

  • Power Evidence Generation: Leverage integrated assessment tools for Quality Improvement Programs (QIP) and Real World Evidence initiatives to capture the real-world data needed to move the needle on clinical practice.

  • Unify Global Collaboration: Create a dedicated “one-stop shop” for faculty and internal teams to co-create everything from patient tools to centralized field learning programs.

And so much more!

Register for free

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

Alternative Approaches to Personalized Medicine in Oncology

Laura Towart, Founder & CEO of My Personal Therapeutics, discusses her company’s approach to precision medicine, the barriers patients with cancer face when trying to access personalized treatments, and how...

Reimagining Healthcare Using Mobile Health Technologies

Kim Shah, CEO of KnowYourMeds, explores digital health, AI, telemedicine, health literacy, and how to ensure a safe return to work amidst the ongoing COVID-19 pandemic. We also dive into...

Gene Editing and Precision Medicine: The Future of Healthcare?

Dr. Oscar Segurado, Chief Medical Officer at ASC Therapeutics, dives into advanced gene therapies, gene editing, and personalized medicine. We also explore the many different hats he wears as CMO, consultant,...

CRM Design and Optimization for Life Science Organizations

John Leombruno, CEO of OkRx, shares how his company is working to improve PSP strategy and operations in Canada. He also discusses the impact of COVID-19 on PSPs, digital transformation, clinical...

Enabling Patient-Focused Research Through Virtual Clinical Trials

Chad Walsh, CEO of Sciteline, dives into virtual trials, including their benefits, barriers, and impact on patient-centricity. Among other things, we will discuss data privacy concerns, the role of digital...

Innovative Approaches to Managing Mental Health Conditions

Owen Muir, MD, CIO at Brooklyn Minds, explores the secondary effects of COVID-19 on mental health conditions, along with techniques such as deep Transcranial Magnetic Stimulation (dTMS), Mentalization-Based Treatment (MBT), and...

Looking back at the year when everything changed

COVID-19 has impacted every aspect of our lives, from the way we shop for groceries to the way we conduct work and interact with healthcare providers and our families.

PRESS RELEASE: IMPETUS DIGITAL LAUNCHES INSITE EVENT™

Impetus Digital launches InSite Event™ -  the most comprehensive virtual event platform for life science companies, delivered with white glove service

Risk Management, Ethics, and Compliance Considerations in the New Normal

Myriam Prescott, Head of Ethics, Risks and Compliance - Oncology, Novartis Canada, dissects the importance of effective patient engagement and strong compliance & monitoring programs. We also dive into the...